Related references
Note: Only part of the references are listed.Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients
Daisuke Toki et al.
TRANSPLANT INTERNATIONAL (2009)
Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies
Ronald P. Taylor et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
ABO Blood Type Incompatible Kidney Transplantation Without Splenectomy Prepared With Plasma Exchange and Rituximab
T. Chikaraishi et al.
TRANSPLANTATION PROCEEDINGS (2008)
Pharmacodynamics of rituximab in kidney allotransplantation
H. Genberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Extremely high titer of anti-human chimeric antibody following re-treatment with rituximab in a patient with active systemic lupus erythematosus
K Saito et al.
RHEUMATOLOGY (2005)
ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment
DL Segev et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics
CA Vieira et al.
TRANSPLANTATION (2004)
Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan
K Takahashi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys
C Schröder et al.
TRANSPLANT IMMUNOLOGY (2003)
Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab
G Tydén et al.
TRANSPLANTATION (2003)
B lymphopenia in uraemia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2
G Fernández-Fresnedo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Share Paper
